Medicine & Life Sciences
Patient Reported Outcome Measures
100%
Neoplasms
62%
Breast Neoplasms
58%
Trastuzumab
57%
Quality of Life
42%
Terminology
37%
Primary Myelofibrosis
34%
Polycythemia Vera
32%
Clinical Trials
32%
Lapatinib
25%
Therapeutics
25%
human ERBB2 protein
23%
Essential Thrombocythemia
21%
National Cancer Institute (U.S.)
20%
Survival
19%
INCB018424
18%
Drug Therapy
16%
Symptom Assessment
14%
Fatigue
14%
Disease-Free Survival
14%
Apolipoprotein E4
13%
Randomized Controlled Trials
13%
Melanoma
13%
Research Personnel
11%
Cognitive Dysfunction
11%
Mastectomy
10%
Confidence Intervals
10%
Lenalidomide
10%
Breast
9%
Prostatic Neoplasms
9%
palbociclib
9%
Recurrence
9%
Cognitive Aging
8%
Pain
8%
Memory
8%
Hydroxyurea
8%
Glioblastoma
8%
RG7388
7%
Alzheimer Disease
7%
Progression-Free Survival
7%
Multiple Myeloma
7%
Cyclophosphamide
7%
Glioma
7%
Dexamethasone
7%
Sentinel Lymph Node Biopsy
7%
Carpal Tunnel Syndrome
7%
Triple Negative Breast Neoplasms
7%
Biopsy
7%
Cerebral Blood Volume
7%